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 Abstract 
 
Background Several studies have assessed the impact of chronic obstructive pulmonary 
disease (COPD) on work ability and work productivity, however this relationship is poorly 
understood.  
 
Aims To undertake a systematic review to assess the effects of COPD on employment, 
absenteeism and presenteeism.  
 
Methods A comprehensive search using CINAHL, Embase, MEDLINE and The Cochrane 
Library, was conducted to include epidemiological studies from 1937 to August 2017. One 
reviewer screened all citations. Shortlisted full-text articles were independently assessed by 
a second reviewer. Data were extracted by one reviewer with a random sample of papers 
(45%) checked by a second reviewer.  
 
Results Forty-four studies were included; the majority of evidence was from cross-sectional 
studies, and some cohort studies. COPD patients had lower employment rates than those 
without COPD. Among those in work, most studies showed patients with COPD took more 
time off work than those without and reported poorer work performance (presenteeism), 
although evidence for this association was weaker. The influence of disease severity on 
these outcomes was unclear, however it appeared that increasing severity of airflow 
obstruction was associated with reduced likelihood of being employed. A number of 
methodological limitations were found amongst the evidence, including the lack of 
adjustment for important confounders.  
  
Conclusions Future studies are required which assess the impact of COPD on presenteeism 
using validated presenteeism instruments and consistent reporting methods. Robust studies 
are now needed to identify modifiable factors associated with these poorer working 
outcomes to inform future interventions aimed at improving work productivity among those 
with COPD. 
 
Key words: Chronic obstructive pulmonary disease; employment; absenteeism; sickness 
absence; presenteeism; work performance; work productivity; systematic review 
 
 Introduction 
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterised by 
airflow obstruction and increasing breathlessness.1 It is the fourth leading cause of death 
worldwide2;3 and is associated with high healthcare utilisation costs; costing the UK National 
Health Service (NHS) more than £800 million annually.4 However the additional societal 
costs attributable to the condition, mainly deriving from lower work productivity, are even 
greater, with estimates ranging from £1.1 billion and £2.7 billion annually.4;5 In the UK, an 
estimated 44% of the COPD population are below retirement age, and around one quarter 
are not in work due to their COPD.5 For those who are in employment, an estimated 5% of 
sickness absence is due to COPD.5  
A number of studies have indicated that patients with COPD have lower employment rates 
compared to those without COPD,6-8 and this appears to be more marked amongst those 
with more severe disease.8 Furthermore, COPD may also be responsible for increased 
absenteeism9 and presenteeism10 (poor work performance when at work). 
However, studies examining the effect of COPD on employment and work productivity are 
not always consistent, and have been conducted in a variety of settings and populations.  
There are no previous comprehensive reviews of the evidence in this area. The aim of this 
review was to summarise the findings of these studies and to identify the key disease 
related factors that are associated with poorer working outcomes among those with COPD. 
This will inform the development of future interventions to help improve work productivity 
within this population.   
 
 
 Methods 
We undertook a systematic review to evaluate the evidence on the relationship between 
COPD and employment, absenteeism and presenteeism. Cohort or cross-sectional studies of 
COPD patients from any setting, which measured employment, absenteeism or 
presenteeism among COPD patients compared with participants without COPD were sought.  
To ensure that the effect of disease severity was considered, only studies where a 
standardised measure of disease severity or impact of symptoms was used were considered.  
A comprehensive search was conducted using CINAHL, Embase, MEDLINE and The Cochrane 
Library electronic databases to identify relevant studies published from 1937 until August 
2017. The combination of keywords used were: (“chronic obstructive pulmonary disease” or 
“COPD” or “chronic obstructive airways disease” or “chronic obstructive lung disease” or 
“emphysema” or “chronic bronchitis”) and (“employment” or “employed” or “absenteeism” 
or “day off” “sickness absence” or “sick leave” or “presenteeism” or “work productivity” or 
“work performance” or “occupational health”). MeSH terms and text words were used. All 
relevant epidemiological studies were included. Citation lists were scanned to identify 
additional relevant articles. Non-English language articles were excluded. 
One reviewer (KR) screened all titles and abstracts and relevant full-text articles. The 
shortlisted citations were independently assessed by another reviewer (RJ). The first 
reviewer extracted the data using an agreed data extraction form. For a random sample of 
45% of papers, a second reviewer checked data extraction. Outcome measures of interest 
included: objective or subjectively reported employment, absenteeism (including mean 
number of days or hours off work; proportion of patients reporting time off work) and 
presenteeism (including mean presenteeism score; number of hours affected by 
 presenteeism; proportion of patients reporting presenteeism). Due to the various 
definitions we used a known definition of presenteeism for the purpose of this review: “the 
problem of workers being on the job, but, because of illness or other medical conditions, 
not fully functioning”11; therefore studies measuring the impact of COPD on work 
performance or working limitations were included, irrespective of whether a validated 
presenteeism tool was used. Articles that did not compare those with COPD to those 
without COPD or assess the effect of disease severity on one of the three outcomes 
measures were excluded. For studies that did not report data in the text or tables, estimates 
were extracted from graphs or calculated using the available data (i.e. proportions).  
The methodological quality of the included studies was assessed by the first reviewer, with a 
random sample of 45% of papers, checked by the second reviewer using an adaptation of 
the Cochrane risk of bias method12 and a combination of questions from Crombie13 and the 
Critical Appraisal Skills Programme (CASP) cohort tool14; which was piloted and adjusted as 
necessary (see supplementary table S2 for quality assessment criteria). Risk of bias was 
classified as high, low or unclear. 
 
 
 
 
 
 
 
 
 
 Results 
Of 3108 citations (after excluding duplicate citations), 44 relevant studies met the inclusion 
criteria. The effect of COPD on employment was assessed in 20 studies6-8;15-31; 35 assessed 
absenteeism,9;10;15-20;22;28-53 and 21 presenteeism.9;10;15-17;22;28;29;31;32;37-41;45;46;48;50-52 
Table 1 summarises the main characteristics and findings for higher quality studies that used 
spirometry to diagnose COPD or measure airflow obstruction and also adjusted for 
important confounders within their analyses (full details of all studies in supplementary 
tables S1 to S8). 
 
Two cohort studies23;27 and 5 cross-sectional studies6-8;24;30 compared employment rates 
among those with and without COPD. Two cross-sectional studies compared early 
retirement rates in those with COPD30 and chronic bronchitis20 to those without COPD30 and 
asthma.20 Four cross-sectional studies assessed employment rates,16;22;29 retirement 
rates,16;22;29 unemployment rates16;22;29 and the inability to work31 among those with various 
respiratory conditions.  
 
The cohort studies, based on the Health and Retirement Study in the USA27 and the National 
Patient Registry in Denmark,23 collected data over 16 and 12 years, respectively. (Note: 
Snider et al’s27 analysis described as longitudinal, however it is unclear how timeframe was 
accounted for within the analysis). Among the 10 cross-sectional studies, 5 were general 
population samples,6-8;24;31 4 primary/secondary care populations,16;22;29;30 and one was a 
smaller study consisting of a subgroup of people identified from a general population 
 sample, comparing those with chronic bronchitis symptoms with people who reported 
asthma symptoms.20  
 
Consistently across 6 studies, patients with COPD had significantly lower employment rates 
than those without COPD,6-8;23;27;30 or those with asthma6 and other chronic conditions6; 
with odds ratios (ORs) ranging from 0.4 (95% confidence intervals (CI): 0.2 – 0.7) (COPD 
compared to no chronic conditions)6 to 0.8 (0.7 – 1.00) (COPD compared to no COPD).7 
Furthermore, once out of work, COPD patients were less likely to re-join the workforce 
compared to those with no chronic conditions (OR: 2.92; 95% CI: 1.35 – 6.29).6 Similar 
patterns were reported in an age-group adjusted analysis of serial cross-sections of the 
general US population24; employment rates were consistently lower among those with self-
reported COPD compared to those without (49.7% vs. 59.7% during 1980-82 and 57.5% vs. 
64.6% in 1994-96).  
 
Two further cross-sectional studies showed that those with COPD and chronic bronchitis 
had higher rates of early retirement, compared with those without COPD30 and those who 
had asthma symptoms.20  
 
The final four cross-sectional studies compared COPD with other respiratory conditions. A 
general population study (n=8855), found that those with self-reported emphysema had 
higher unemployment (62.9%) compared to those with chronic bronchitis (18.4%) and 
asthma (25.2%), with a higher proportion also attributing this to their lung condition (27.4% 
vs. 0.6% and 4.8% respectively).31 The remaining three studies were part of a series based 
on the same protocol carried out in India,16 Taiwan22 and Thailand29. Study samples included 
 approximately 1000 people, recruited from various health settings, and found lower 
employment rates and higher early retirement rates in those with COPD compared to those 
with asthma, allergic rhinitis and rhinosinusitis (no statistical tests reported).16;22;29  
 
Eleven studies (2 cohort and 9 cross-sectional) assessed the relationship between COPD 
disease severity and employment.7;8;15;17-19;21;25;26;28;30 The two cohort studies (with 1 year 
follow-ups) were based on COPD patients (n=24419; n=21218) in northern Sweden and both 
found higher likelihood of early retirement with increasing airflow obstruction (p<0.01), but 
neither adjusted for important confounders.18;19  
 
Among 7 cross-sectional studies assessing effects of airflow obstruction, only 3  found a 
statistically significant inverse relationship with employment,8;21;28 including one high quality 
study, from the USA which adjusted for a range of confounders.8 Another cross-sectional 
study, based on a large (n=2139) primary/secondary care population with COPD, indicated 
trends of lower employment and higher early retirement with increasing airflow 
obstruction, however no statistical tests were reported.30  The remaining studies showed no 
association and were of varying quality.  
 
Three studies assessed other measures of disease severity: symptoms score15 
(breathlessness, coughing, infection, mucous production and wheezing), modified Medical 
Research Council (mMRC) score17;26 and the body-mass index, airflow obstruction, dyspnoea 
and exercise capacity (BODE) index.26 All showed lower employment rates with increasing 
severity, including one study which adjusted for all relevant confounders.26 
 
 Twenty-three studies assessed sickness absence.9;16;20;22;29-32;35;37-40;42-45;47;49-53 Thirteen 
measured absenteeism9;30;32;37-40;42;43;47;49;50;53 and two assessed disability days32;35 (sick leave 
covered by insurance programmes54) in people with COPD compared to those without. Eight 
studies compared absenteeism in people with COPD to those with other respiratory 
diseases16;20;29;31;44;51-53 and one in people with or without airflow limitation.45 The majority 
were large studies in workplaces,9;32;35;42;43;45;50 the general population,31;37-40;44;49;53 primary 
care47 or a combination of primary and secondary care.16;22;29;30;51;52  
 
Two large retrospective matched cohort studies (up to 12 months follow-up), from US 
workplaces measured disability days (short-term,32;35 long-term32;35 and a combination of 
the two35), and found a significantly increased risk of disability in those with COPD 
compared to those without. Data on disability days were extracted from the employee’s 
company database, however the definitions lacked clarity. 
 
Five studies20;30;31;42;44 reported the proportion of COPD patients affected by sickness 
absence and one45 reported the proportion of those with absenteeism who had airflow 
limitation. All used self-reported absenteeism and recall periods varied from two weeks31 to 
six years.42 The cohort study found higher absenteeism among people with, compared to 
those without COPD over six years (95.5% vs. 82.4%).42 Of the three cross-sectional studies, 
two found that a greater proportion of people with COPD or airflow limitation reported 
absenteeism (over 12 months) compared to those without.30;45 Two further studies found 
higher absenteeism among those with asthma compared to those with COPD, but neither 
adjusted for confounding.19;43  
 
 Nine cross-sectional studies assessed whether work time missed over one-week differed 
among those with, from those without COPD (n=4) or with other respiratory diseases (n=5). 
Whilst two found no significant difference,38;39 the two larger studies (n=6038937; 
n=5837840) found significantly higher absenteeism rates in those with COPD compared to 
those without (4.3% vs. 2.6%, p<0.00137; 8.71% vs. 6.93%, p=0.000840) in adjusted analyses. 
The remaining five studies (from the same series) found greater absenteeism in those with 
rhinosinusitis compared to people with COPD (no statistical tests reported).16;22;29;51;52 
 
Four of the five cross-sectional studies that compared the risk of absenteeism in those with 
COPD or airflow limitation with those without, had similar trends. The remaining  Canadian 
study found no significant difference between those with and without COPD.49 However, 
there was a lack of adjustment for important potential confounders. 
 
Ten studies (4 cohort32;35;42;43, 6 cross-sectional30;31;38;39;47;50) compared the amount of time 
off work among people with and without COPD. Three of the cohort studies35;42;43 
(occupational) found that people with COPD had more time off work whilst the fourth32 
found this in only one of the two time periods assessed. The largest of these studies 
matched for a number of important factors, and had an 8 year follow-up (mean days off 
work per month 1.0 in those with vs. 0.6 without COPD; incident rate ratio=1.53).43 The 
remaining cross-sectional studies demonstrated similar patterns, although five of the six 
31;38;39;47;50 did not adjust for some important confounders.  
 
The mean number of days off among patients with COPD ranged from 1.6 (projected) to 
12.0 (calculated) days over 12 months.31;43 However, the latter (1 day per month/per 
 patient) may provide a more reliable estimate as in this cohort study COPD diagnosis and 
sickness absence rates were taken from medical reports and the company database, 
respectively.43  
 
The relationship between disease severity and absenteeism was assessed in fifteen 
studies10;15;17-19;28;30;33;34;36;37;41;45;46;48; of which two cohort18;19 and three cross-sectional 
studies28;33;46 found no associations, even after adjusting for a range of confounders in two 
of the studies.33;46 Two large and one smaller cross-sectional study did show a positive 
association (p<0.05) between airflow obstruction and sickness absence, however none 
adjusted for confounders.34;36;48 Another two studies found a similar pattern but reported 
no statistical tests.30;45  
 
Five large and one smaller cross sectional study investigated the impact of other measures 
of disease severity: the COPD Assessment Test (CAT) score,41 symptom score,15 mMRC/MRC 
score10;17;46 and perceived disease severity.37 Three studies15;41;46 found greater symptoms 
were associated with an increased risk of sickness absence after adjusting for a number of 
confounders (MRC 4 and 5 vs. MRC 1: OR=13.83; 95% CI 3.78 – 50.5646). One found greater 
perceived disease severity was associated with a higher rate of sickness absence (adjusted 
p<0.001).37 Two further studies, although not statistically significant, indicated that 
increased breathlessness was associated with greater absenteeism.10;17  
 
Fourteen cross-sectional studies assessed the effect of COPD on work performance. Studies 
were drawn from workplaces,9;32;45;50 primary/secondary care16;22;29;51;52 or the general 
population.31;37-40  
  
The assessment of presenteeism varied widely between studies. Nine large cross-sectional 
studies used the Work Productivity and Activity Impairment (WPAI) questionnaire; of which 
three were based in the USA37-39 and six in Asia.16;22;29;40;51;52 Four large general population 
based studies found that people with COPD were significantly more likely to report 
presenteeism compared to those without COPD (p<0.001), after adjusting for confounders. 
The remaining five Asian studies (same series) found poorer presenteeism scores among 
those with asthma, allergic rhinitis and rhinosinusitis compared to those with COPD (no 
statistical data reported).16;22;29;51;52  
 
Two cross-sectional studies used the World Health Organization Health and Work 
Performance Questionnaire (WHO-HPQ).9;50 Although both found no significant association, 
one suggested COPD patients might be at increased risk of presenteeism.9 
A serial cross-sectional study based in a large US company obtained data over two time 
periods using two presenteeism questionnaires: the Work Limitation Questionnaire (WLQ) 
and the Health and Work Productivity-One Survey (HWP-1).32 The study found that 
presenteeism was greater among those with COPD compared to matched cases who did not 
have COPD at the 1st time point (p<0.05), although no significant association was seen at the 
other time point.  
 
One cross-sectional study based on an employed Japanese population of 1378 people, 
consisting of a smaller sample of people with airflow limitation (n=98), assessed the impact 
of airflow limitation on perceived quantity and quality of work,45 and found that after 
adjusting for a number of confounders, those with moderate to severe airflow limitation 
 were approximately twice as likely to report lower work quality (adjusted OR=2.04; 95% CI 
1.12 – 3.71) and quantity scores (adjusted OR=2.19; 95% CI 1.21 – 4.00) compared to those 
with no airflow limitation.  
 
The final cross-sectional study was based on a US general population survey (n=8855) and 
found that those with self-reported emphysema (43.5%) were more affected at work due to 
their condition compared to those who reported asthma (19.1%) and chronic bronchitis 
(3.4%).31 
 
Nine studies assessed the relationship between disease severity and 
presenteeism.10;15;17;28;37;41;45;46;48 Disease severity was measured using various methods: 
degree of airflow obstruction28;45;46;48 (n=4), CAT score41 (n=1), symptom score15 (n=1), 
breathlessness10;17;46 (n=3) and perceived disease severity.37  
 
An association between severity of airflow obstruction and work performance were 
indicated in three studies (no adjustment for confounding),28;45;48 but not the fourth.46 
Significant associations were found between poorer work performance and greater CAT 
scores41 (CAT score 30-40 vs. CAT score 0-9: adjusted coefficient: 1.68; 95% CI 1.39 – 1.97), 
symptoms15 (always vs. do not always experience a symptom: adjusted coefficient= 0.06; 
95% CI 0.04 – 0.08) and breathlessness17;46 (MRC score 4 and 5 vs. MRC score 1: adjusted 
OR=18.11; 95% CI 2.93 – 112.1146). The last study, assessed perceived level of disease 
severity, and found a significant positive association with presenteeism (adjusted mean % 
presenteeism: 22.7% (mild), 27.3% (moderate) and 35.3% (severe); p<0.001).37 
 
 Discussion 
Although the prevalence of employment among COPD patients varied from 13.3% to 
69.2%,8;22  there was clear and consistent evidence across settings and populations that 
employment rates among patients with COPD were lower compared to those without. This 
was observed in a 16 year cohort study,27 a large matched retrospective cohort study23 as 
well as five large cross sectional studies.6-8;24;30 Supporting these findings was some weaker 
evidence that as disease severity increased patients were less likely to be in paid 
employment.  
Despite the inconsistencies in recall periods (1 week to 6 years) and wide variation in the 
period of data collection (1964 to 2013) strong evidence from 1 cohort study43 in addition to 
some evidence from other cohort studies32;35;42 demonstrated that patients with COPD took 
more time off work compared to those without. Five cross-sectional studies with some 
methodological weaknesses also supported these results.30;38;39;47;50 A reliable estimate of 
the extent of absenteeism was that COPD patients took an average of 12 days off over 12 
months compared to 7.2 days in those without COPD.43 Furthermore, when measuring 
disability-related work loss, there was clear evidence from a cohort study that COPD 
patients were approximately twice as likely to have a short term disability and more than 4 
times as likely to have long term disability compared to those without COPD.35  
The evidence for associations between disease severity (measured by airflow obstruction) 
and absenteeism was inconsistent, and comparison of study findings was difficult due to 
methodological weaknesses (e.g. small sample sizes, lack of adjustment for confounders), 
differences in measures of disease severity, and measures of absenteeism. There was 
 however, increasing evidence from adjusted analyses that absenteeism was worse among 
people with greater symptoms. 
For presenteeism, there was weak evidence that patients with COPD had poorer work 
performance than those without, with some inconsistency in findings. Due to the various 
scales used to measure presenteeism it was difficult to quantify these differences.  Some of 
the inconsistencies may be attributable to gender and age differences between samples.32 
There was conflicting evidence on the effect of disease severity on work performance, in 
particular the relationship with airflow obstruction. Similar to the data on absenteeism, 
analyses using other measures of disease severity did show significant associations with 
work performance; of which the majority were adjusted for the effect of confounding.  
There were some well-conducted observational studies included in this review, which either 
matched or adjusted for a range of important covariates. However, adjustment for 
confounders or important confounders was an identified problem among many studies, 
making it difficult to interpret the reported effect sizes. Additionally, some studies did not 
go beyond descriptive statistics and hence, reported no effect size. Many studies also 
displayed limited external validity.   
This is the first comprehensive systematic review, assessing the effect of COPD on work-
related outcomes. However, the review had some limitations. Firstly, it was restricted to 
publications in English. Only one reviewer screened all citations from the electronic 
databases. A standardised tool was not available to evaluate the methodological strength of 
the evidence. However, to our knowledge, there is currently no gold-standard tool to assess 
bias within cross-sectional studies. There was high heterogeneity between the studies, 
making it difficult to compare and synthesise the results.  
 
 Two other reviews have been published55;56; despite the differences in the methodology of 
these compared to the current review, the main results were broadly similar. However, 
Patel et al’s56 study focused on studies within the USA, and little was discussed on the 
effects of COPD disease severity on work outcomes in Chaker et al’s study.55  
 
Due to the methodological weaknesses found within the current literature, the following are 
required for future studies: prospective studies with matched controls or better control of 
confounders; use of validated scales; methods of data collection to minimise recall error 
(e.g. routine data on sickness absence, or data from company records) and robust methods 
in diagnosing lung disease (i.e. spirometry data). Future studies should measure work 
performance using an agreed and standardised questionnaire and recall periods, to allow 
comparisons between studies. 
 
Whilst the effect of airflow obstruction on outcomes was unclear, we did find associations 
between other measures of disease severity and employment, absenteeism and 
presenteeism.15;26;41;46 This supports findings from other literature that other measures, 
such as extent of breathlessness, may be more important for assessing severity in relation to 
impact on outcomes in patients with COPD.  
 
Poorer employment and work productivity among people with COPD may be partly 
attributable to their work conditions or to poor disease management. It is important to raise 
awareness among employers and for better liaison between the workplace and the 
employees’ health providers.  Employers could provide support by ensuring access to 
smoking cessation programmes and time for employees to attend relevant self-
 management programmes.1 They could also support employees by undertaking workplace 
risk assessments and adjusting their work tasks to reduce the risk of triggering 
exacerbations.57 By promoting the health of employees with chronic disease, employers will 
not only benefit the patient, but also improve work productivity in their workforce. 
 
This review highlighted the lack of strong evidence on the effect of COPD on presenteeism, 
and suggests that the presence of symptoms rather than airflow obstruction impact on 
outcomes. Longitudinal studies, using standardised instruments and sufficient data to adjust 
for confounders, are required to confirm these observations. There is also a need to 
understand how to support COPD patients to remain in work and improve their work 
productivity. In order to inform interventions, we need to understand which modifiable 
aspects of the disease, personal or work characteristics contribute to the burden of COPD 
on work. Such interventions are needed to benefit both the physical and mental health and 
wellbeing of patients, as well as to benefit society.  
 
Key points: 
 Patients with chronic obstructive pulmonary disease have lower employment rates 
and take more time off work compared to those without COPD. 
 There is conflicting evidence about the effects of airflow obstruction on work-related 
outcomes, however there is evidence that symptoms are important; longitudinal 
studies are needed to confirm this. 
 Better understanding of the modifiable factors associated with lower employment 
rates and poorer work productivity are needed to help design effective interventions. 
  Further research is required, particularly  prospective studies which account for 
relevant confounders, use robust methods in diagnosing COPD, measure absenteeism 
and presenteeism using agreed and standardised questionnaires and recall periods, 
and allow comparison of data between studies. 
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 Table 1 Characteristics and results of the higher quality studies which used spirometry to diagnose chronic obstructive pulmonary disease (COPD) or 
measure airflow obstruction and accounted for confounders within the analyses 
 
Author, 
country 
Study design, setting, 
study period 
Characteristics of participants 
Study results 
Comments  
Cohort studies 
Lokke et al 
(2014)23 
 
Denmark 
  
Retrospective 
matched cohort (up to 
12yr follow up) 
Patient records from 
national patient 
registry 
1998 – 2010 
N=263622 (n=131811 COPD) 
Mean age (years): unknown 
 
Male %: unknown 
 
FEV1% predicted: unknown 
% with income from employment 
Some baseline characteristics 
unknown therefore generalisability of 
sample is unclear.   
Although many socio-demographic 
factors matched, some important 
factors not adjusted for.  
COPD:                     
No COPD:               
P value: 
16.7%& 
23.8% 
<0.01 
Nair et al 
(2012)43 
 
USA  
Retrospective 
matched cohort (up to 
8yr retrospective 
follow up) 
 
Workplace based 
population from 
claims database 
2000 – 2007 
 
N=55224 (n=27612 COPD) 
Mean age (years): 
COPD: 44.5; Non-COPD: 43.8 
 
Male (%): 
COPD: 59; Non-COPD: 60 
 
FEV1% predicted: unknown  
 
COPD: 
No COPD: 
Incident rate ratio: 
Mean absenteeism hours per month 
5.6 hours 
3.8 hours 
1.21 
Mean days off work per month 
1 day 
0.6 days 
1.53 
Disease severity unknown. Although 
accounted for many confounders, 
including a variety of co-morbidities, 
not all relevant co-morbidities were 
accounted for as well as smoking 
status. 
Darkow et al 
(2007)35 
 
USA 
Retrospective 
matched cohort (90-
365 days retrospective 
f/up) 
 
Workplace based 
population from nine 
multistate companies 
using a claims 
database 
2001 – 2004 
 
N=4045 (n=1349 COPDs) 
Mean age (years) (SD): 
COPD: 52.1 (6.0) 
Control: 51.9 (6.0) 
 
Male (%) 
COPD: 51 
Control: 51.9 
 
FEV1% predicted: unknown 
 
 
Disability rates adjusted for length of 
follow-up and co-morbidities (%) 
COPD: 
No COPD: 
Odds ratio (OR) (95% CI): 
 
Mean days (disability days adjusted for 
co-morbidities and follow-up) 
COPD: 
No COPD: 
P value: 
 
 
Respiratory related disability, n(%) 
COPD: 
No COPD: 
Short-term disability 
 
 
 
21.8% 
7.0% 
2.11 (1.64 – 2.71) 
 
 
 
51.3 days 
44.0 days 
0.16 
 
 
 
92 (6.8%) 
18 (0.7%) 
Long-term 
disability 
 
 
2.4% 
0.4% 
4.21 (1.93 – 9.16) 
 
 
 
76.4 days 
85.9 days 
Not reported 
(adjusted for f/up 
only) 
 
10 (0.7%) 
0 (0%) 
 
Any disability  
 
 
 
22.8% 
7.3% 
2.15 (1.68 – 2.75) 
 
 
 
58.6 days 
44.9 days 
0.01 
 
 
 
- 
- 
Limited range of occupations 
included. Outcome measures taken 
from database (not self-report). 
Follow up length differed between 
the groups, but was adjusted for. 
Short-term and long-term disability 
criteria unclear.  Smoking status not 
accounted for.  
 
  
     
Author, 
country 
Study design, setting, 
study period 
Characteristics of participants Study results Comments 
Cross-sectional studies 
Ding et al 
(2017a)41 
 
China, Europe 
and USA 
 
Cross-sectional 
 
Primary and 
secondary care COPD 
population 
2010 and 2013 
N=2166 
Mean age (years) (SD):  
65.1 (10.7) 
 
Sex (male) (%): 66.6 
 
FEV1 % predicted: 61.9 
 
COPD Assessment Test (CAT) score 
0 – 9 score:  
10– 19 score:  
20 – 29 score:  
30 – 40 score: 
Coefficient (95% CI):  
P value: 
Work time missed (%) 
 
0.1(1.1%) 
3.3 (13.9%) 
9.4 (23.4%) 
8.4 (24.3%) 
0.445 (0.169 – 0.720) 
0.002 
Presenteeism score (%) 
 
6.9 (9.2%) 
19.5 (15.7%) 
33.8 (18.8%) 
51.7 (21.8%) 
1.68 (1.392 – 1.967) 
<0.001 
 
Adjusted for: age, BMI, smoking 
status and history, physician 
confirmed diagnosis of depression, 
anxiety and serious cardiovascular 
conditions. Presenteeism definition 
unclear (e.g. due to COPD or general 
health). 
Rai et al 
(2017a)26 
 
UK 
Cross-sectional 
 
Primary care COPD 
population 
2012 – 2014  
N=608 
Age (years) (n, %):  
38 – 49: 68 (11.2) 
50 – 59: 253 (41.6) 
60 – 64: 287 (47.2) 
 
Sex (male) (%): 56.4 
 
FEV1 % predicted: unknown 
 
 
 
 
OR (95% CI) for the 
likelihood of being in paid 
employment according to 
disease severity 
 
P for trend: 
Modified BODE 
index score quartiles 
 
 
1: 1.0 (reference) 
2: 0.84 (0.48 – 1.47) 
3: 0.38 (0.19 – 0.74) 
4: 0.10 (0.03 – 0.33) 
 
mMRC score 
 
 
 
0 – 1: 1.0 (reference) 
2: 1.18 (0.64 – 2.18) 
3: 0.23 (0.08 – 0.62) 
4: 0.36 (0.15 – 0.85) 
 
<0.01 
Airflow obstruction 
(postbronchodilator FEV1 
% predicted) 
 
>65: 1.0 (reference)  
50-65: 0.84 (0.40 – 1.77) 
34-49: 0.80 (0.38 – 1.71) 
<35: 0.41 (0.16 – 1.03) 
 
0.60 
Adjusted for age, sex, smoking status, 
education, number of comorbidities, 
disease severity (BODE index 
score/components of the BODE 
index) and occupational exposures to 
vapours, gases, dusts and fumes. 
Rai et al 
(2017b)46 
 
UK 
Cross-sectional 
 
Primary care COPD 
population 
2012 – 2014 
N=348 
Age (years) (n, %):  
38 – 49: 38 (10.9) 
50 – 59: 122 (35.1) 
60 – 64: 88 (25.3) 
>65: 100 (28.7) 
 
Sex (male) (%): 62.4 
 
FEV1 % predicted: unknown 
 
Airflow obstruction according 
to GOLD staging 
 
Mild: 
Moderate: 
Severe and very severe: 
 
MRC dyspnoea score 
1: 
2: 
3: 
4 and 5: 
Likelihood of high absenteeism 
according to disease severity,  
OR (95% CI) 
 
1.00 (reference) 
1.00 (0.39-2.58) 
1.84 (0.54 – 6.27) 
 
 
1.00 (reference)  
0.46 (0.12 – 1.78) 
2.65 (0.72 – 6.24) 
13.83 (3.78 – 50.56) 
Likelihood of poor work performance 
according to disease severity,  
OR (95% CI) 
 
1.00 (reference)  
1.08 (0.40 – 2.90) 
1.03 (0.26 – 4.09) 
 
 
1.00 (reference)  
0.83 (0.28 – 2.48) 
2.65 (0.88 – 7.95) 
18.11 (2.93 – 112.21) 
Adjusted for age, sex, smoking status, 
social deprivation, number of 
comorbidities, GOLD stage, MRC 
score, usual working hours 
(absenteeism analysis only), 
occupational exposures to vapours, 
gases, dusts and fumes (presenteeism 
analysis only) and length of current 
employment (presenteeism analysis 
only) 
      
Author, 
country 
Study design, setting, 
study period 
Characteristics of participants Study results Comments 
Cross-sectional studies 
Onoue et al 
(2016)45 
 
Japan 
Cross-sectional 
 
Employed population  
2012 - 2013 
N=1378  
(n=98 with airflow limitation) 
Characteristics not reported for 
whole sample (split into 3 
categories according to airflow 
limitation). See supplementary 
tables for details.  
 
 
Sick leave according to 
airflow limitation,  
n (%) 
 
OR (95% CI): 
P value: 
No airflow 
limitation (AL) 
 
 
410 (39.5%) 
 
Reference 
- 
Mild AL 
 
 
 
15 (41.7%) 
 
1.36 (0.67-2.76) 
0.40 
Moderate to severe AL 
 
 
 
20 (54.1%) 
 
2.69 (1.33-5.44) 
0.006 
High proportion of males in those 
with AL. Those with certain 
comorbidities excluded from the 
study. Sick leave based on 12 month 
recall period. Adjusted for age, sex, 
BMI, smoking status, hypertension, 
hyperglycaemia, dyslipidaemia, sleep 
duration, work hours per day, 
smoking environment at workplace 
Montes de 
Oca et al 
(2011)7 
 
Latin America 
  
Cross-sectional 
Population based 
survey 
2003 - 2004 
N=5314 (n=759 COPDs)  
Characteristics not reported for 
whole sample (split by COPD 
diagnosis and work status). See 
supplementary tables for 
details.  
 
 
Employment in those 
with COPD vs. no 
COPD 
 
COPD: 
No COPD: 
Adjusted OR (95% CI): 
P value:  
 
Employment 
according to disease 
severity 
 
Employed: 
Not employed: 
P value (adjusted for 
survey design): 
Work for pay, n 
(%)   
 
 
 
317 (41.8%) 
2602 (57.1%) 
0.83 (0.69 – 1.00) 
0.054 
 
 
GOLD stage 1 
 
 
194 (61.2%) 
257 (58.1%) 
 
0.29  
Mean+SE 
months for 
pay(adjusted 
for survey 
design) 
10.5 + 0.17 
10.9 + 0.06 
- 
0.02 
 
 
GOLD stage 2 
 
 
106 (33.4%) 
150 (33.9%) 
 
Mean+SE 
days for pay 
(adjusted for 
survey 
design) 
5.85 + 0.08 
5.71 + 0.03 
- 
0.09 
 
 
GOLD stage 3 
and 4 
 
17 (5.4%) 
35 (7.9%) 
Mean+SE 
hours for 
pay(adjusted 
for survey 
design) 
8.97 + 0.17 
8.75 + 0.06 
- 
0.23 
 
 
Mean FEV1 % 
predicted + 
SE 
78.7 + 1.2 
79.7 + 1.2 
 
0.55  
Health 
problems 
stop person 
from working, 
n (%) 
27 (3.6%) 
196 (4.3%) 
- 
Lack of detail around overall sample 
characteristics. High response rate 
(83.0%) but characteristics between 
responders and non-responders not 
assessed. Range of confounders 
assessed, but not all. 
Boot et al 
(2004)33 
 
The 
Netherlands 
  
Cross-sectional 
Primary care 
COPD/asthma 
population 
 
N=189 (assessed subset of 71)  
Mean age (years) (SD): 
COPD sick leave: 47.8 (9.5);  
COPD no sick leave: 54.0 (6.3) 
Male (%): 
COPD sick leave: 67;  
COPD no sick leave: 62 
FEV1% predicted: unknown 
 
Sickness absence in past 
12 months according to 
disease severity 
 
No sick leave: 
Sick leave: 
P value: 
Mild, n (%) 
 
 
 
 
3 (12.0%) 
9 (19.0%) 
>0.05 
Moderate (IIa),  
n (%) 
 
 
 
17 (65.0%) 
21 (48.0%) 
Moderate (IIb),   
n (%) 
 
 
 
4 (15.0%) 
15 (33.0%) 
Severe, n (%) 
 
 
 
 
2 (8.0%) 
0 (0%) 
Small sample size, fewer females and 
fewer patients with severe disease. 
Although various methods used to 
recruit, little detail on how many 
participants were approached by 
healthcare professional. Although 
answer to sick leave is yes/no, recall 
period is 12 months.  Adjusted for a 
range of confounders. Limited 
information on COPD severity 
classification. 
 
 
      
Author, 
country 
Study design, setting, 
study period 
Characteristics of participants Study results Comments 
Cross-sectional studies 
Sin et al 
(2002)8 
 
USA  
Cross-sectional 
General population 
based survey 
1966 – 1970 
N=12436 (n=1073 COPDs) 
Mean age (years) (SD):  
37.9 (13.2) (overall population) 
 
Male (%): 46.5 
COPD: 58.5 
Non-COPD: 47.4 
 
FEV1% predicted: unknown 
Working in past 2 weeks (%) 
COPD:  
No COPD: 
Reduction in probability of 
being in work (95% CI): 
P value: 
% reduction in employment 
according to airflow 
obstruction compared to those 
without significant airflow 
obstruction: 
P for linear trend: 
 
69.21% 
77.24% 
 
-3.9% (-1.3 to -6.4) 
0.032 
FEV1 % predicted >80% 
(mild) 
 
  
3.4% 
<0.01 
 
 
 
 
 
 
FEV1 % predicted  
30% - 80% (moderate) 
 
 
3.9% 
 
 
 
 
 
 
FEV1 % predicted <30% 
(severe) 
 
 
14.4% 
Although COPD diagnosis was based 
on self-report, disease severity was 
based on GOLD criteria. Did not 
adjust for co-morbidities. 
 
Abbreviations: BODE index, body-mass index, airflow obstruction, dyspnoea and exercise capacity index; CAT, COPD Assessment Test; CI, confidence 
interval; COPD, chronic obstructive pulmonary disease; FEV1 , forced expiratory volume in 1 second; GOLD, Global Initiative for Chronic Obstructive Lung 
Disease; mMRC score, modified Medical Research Council score; OR, odds ratio; SD, standard deviation; SE, standard error.  
